Literature DB >> 6953619

Lack of association of HLA-DR antigens with progressive systemic sclerosis (scleroderma).

M Niks, J Rovenský, S Nyulassy, M Buc, J Stefanovic, D Zitnan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6953619     DOI： 10.1111/j.1399-0039.1982.tb01446.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN： 0001-2815


× No keyword cloud information.
  6 in total

1.  Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).

Authors:  J D Reveille; D Owerbach; R Goldstein; R Moreda; R A Isern; F C Arnett
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

2.  Silica, silicosis, and progressive systemic sclerosis.

Authors:  G K Sluis-Cremer; P A Hessel; E H Nizdo; A R Churchill; E A Zeiss
Journal:  Br J Ind Med       Date:  1985-12

3.  The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

Authors:  M Kuwana; J Kaburaki; Y Okano; H Inoko; K Tsuji
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

4.  Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).

Authors:  J D Reveille; E Durban; M J MacLeod-St Clair; R Goldstein; R Moreda; R D Altman; F C Arnett
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Familial concurrence of pauciarticular syndrome and systemic sclerosis.

Authors:  R M Lewkonia; T J Bowen
Journal:  Clin Rheumatol       Date:  1986-06       Impact factor: 2.980

6.  T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis).

Authors:  A J Barnett; B D Tait; M A Barnett; B H Toh
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.